Allogene Therapeutics, Inc. short interest in 2025
In 2025, Allogene Therapeutics, Inc.'s disclosed short interest ran from 15.43% of shares outstanding on 15 Jan 2025 to 8.04% on 31 Dec 2025, a change of -7.39 percentage points. The year's high was 18.65% on 28 Feb 2025 and its low 8.03% on 15 Dec 2025, averaging 11.96% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.90 days on 31 Jan 2025. Full history: Allogene Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 15.43% (15 Jan 2025)
- End of year
- 8.04% (31 Dec 2025)
- Change
- -7.39 pp
- High
- 18.65% (28 Feb 2025)
- Low
- 8.03% (15 Dec 2025)
- Average
- 11.96%
- Highest days to cover
- 13.90 (31 Jan 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 15.43% | 9.90 | |
| 31 Jan 2025 | 15.28% | 13.90 | |
| 14 Feb 2025 | 16.06% | 5.07 | |
| 28 Feb 2025 | 18.65% | 2.63 | |
| 14 Mar 2025 | 17.50% | 11.66 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 16.00% | 9.89 | |
| 15 Apr 2025 | 15.10% | 10.36 | |
| 30 Apr 2025 | 13.87% | 13.41 | |
| 15 May 2025 | 12.59% | 5.14 | 10-Q filed, results (8-K) |
| 30 May 2025 | 11.31% | 10.40 | |
| 13 Jun 2025 | 11.99% | 9.63 | |
| 30 Jun 2025 | 12.23% | 10.39 | |
| 15 Jul 2025 | 11.94% | 6.79 | |
| 31 Jul 2025 | 11.26% | 6.27 | |
| 15 Aug 2025 | 11.03% | 3.49 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 8.99% | 5.25 | |
| 15 Sep 2025 | 9.14% | 9.49 | |
| 30 Sep 2025 | 8.65% | 5.43 | |
| 15 Oct 2025 | 8.78% | 6.08 | |
| 31 Oct 2025 | 8.61% | 7.68 | |
| 14 Nov 2025 | 8.32% | 8.02 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 8.30% | 7.62 | |
| 15 Dec 2025 | 8.03% | 7.53 | |
| 31 Dec 2025 | 8.04% | 6.36 |
See also: Allogene Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.